Literature DB >> 21239205

[Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].

E Maillard1.   

Abstract

Hepatocellular carcinoma (HCC) is the main type of primary liver cancers and the third most common cause of cancer mortality worldwide. In France, rising number between 5000 and 6000 cases are diagnosed each year. The major risk factor for hepatocellular carcinoma is chronic hepatitis: viral hepatitis B, viral hepatitis C, consumption of alcohol, hemochromatosis. Hepatocellular carcinoma is closely associated to liver cirrhosis, which is a true precancerous state. Because hepatocarcinogenesis is a long and heterogeneous process, there is still much to understand. Many genetic and epigenetic alterations are described leading to changes in cellular signalling cascades involved in regulation of growth, differentiation, apoptosis, motility. Hepatitis viruses play a direct oncogenic role through the interaction between viral and cellular proteins, which control cell homeostasis, or by the integration of hepatitis B virus genome into the host genome. Furthermore, hepatitis viruses play an indirect oncogenic role by causing chronic inflammation and hepatocyte regeneration related to viral hepatopathy. In expectation of a better understanding of hepatocarcinogenesis and new treatments, prevention from risk factors and ultrasonographic screening of patients with cirrhosis should increase prognosis.
Copyright © 2010 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21239205     DOI: 10.1016/j.canrad.2010.11.010

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  10 in total

1.  Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.

Authors:  Hatem Elalfy; Tarek Besheer; Mona M Arafa; Mona Abo-Bakr El-Hussiny; Mahmoud Abd El Latif; Sahar Alsayed Mohamed Alsayed
Journal:  J Gastrointest Cancer       Date:  2018-09

2.  Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).

Authors:  Thomas J Vogl; Patrik Schaefer; Thomas Lehnert; Nour-Eldin A Nour-Eldin; Hanns Ackermann; Emmanuel Mbalisike; Renate Hammerstingl; Katrin Eichler; Stephan Zangos; Nagy N N Naguib
Journal:  Eur Radiol       Date:  2015-06-27       Impact factor: 5.315

3.  Autophagy: A novel therapeutic target for hepatocarcinoma (Review).

Authors:  Zhanggui Wang; Weidong Han; Xinbing Sui; Yong Fang; Hongming Pan
Journal:  Oncol Lett       Date:  2014-02-26       Impact factor: 2.967

Review 4.  Genetic diseases that predispose to early liver cirrhosis.

Authors:  Manuela Scorza; Ausilia Elce; Federica Zarrilli; Renato Liguori; Felice Amato; Giuseppe Castaldo
Journal:  Int J Hepatol       Date:  2014-07-14

5.  Role of leptin receptor (LEPR) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis B virus infection.

Authors:  Zhen Li; Weitang Yuan; Shijie Ning; Jie Li; Wenlong Zhai; Shuijun Zhang
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

6.  Digestive cancers in Morocco: Fez-Boulemane region.

Authors:  Laila Chbani; Imane Hafid; Mohamed Berraho; Chakib Nejjari; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2012-11-02

Review 7.  An update on laboratory diagnosis of liver inherited diseases.

Authors:  Federica Zarrilli; Ausilia Elce; Manuela Scorza; Sonia Giordano; Felice Amato; Giuseppe Castaldo
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

8.  GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.

Authors:  R Lencioni; M Kudo; S-L Ye; J-P Bronowicki; X-P Chen; L Dagher; J Furuse; J F Geschwind; L Ladrón de Guevara; C Papandreou; T Takayama; S K Yoon; K Nakajima; R Lehr; S Heldner; A J Sanyal
Journal:  Int J Clin Pract       Date:  2013-11-28       Impact factor: 2.503

9.  Predictors of Developing Hepatocellular Carcinoma in Treated HCV-Carriers in Morocco according to University Hospital Experience.

Authors:  Younès Cherradi; Rajaa Afifi; Hanaa Benbrahim; Wafaa Essamri; Imane Benelbarhdadi; Fatima Zahra Ajana; Hadj Omar El Malki; Mustapha Benazzouz; Abdellah Essaid
Journal:  ISRN Hepatol       Date:  2012-12-23

10.  Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.

Authors:  Tanja Zitzelsberger; Roland Syha; Gerd Grözinger; Sasan Partovi; Konstantin Nikolaou; Ulrich Grosse
Journal:  Cancer Imaging       Date:  2018-05-02       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.